undamentalytics Newsletter
Sign in

Foundation

Bill & Melinda Gates Foundation

13F for the quarter to September 30, 2024, filed November 14, 2024 · SEC CIK 1663801

This manager has not filed a 13F since the one for the quarter to September 30, 2024. The holdings below are from that filing, and the copy ends when the next one would have been due.

Reported value
$43.5m
72% in companies we cover
Positions we cover
3
Largest BNTX 40.6%
Copy, a year
−8.7%
S&P 500 +12.6%
Copy Sharpe ratio
0.00
S&P 500 0.62

How copying its 13F would have done

$10.0k$20.0k 20212022202320242025 $16.1k$6.9k
CopyS&P 500 $10,000 copying Bill & Melinda Gates Foundation's filed holdings in companies we cover from February 19, 2021, buying on the first trading day after each 13F was filed and holding until the next, against the S&P 500 (total return). Marked weekly, log scale. Before costs and taxes; misses trading within each quarter and anything 13F does not show (shorts, cash, bonds, non-US holdings).

Biggest drop −70.4% (S&P 500 −23.9%); beta 0.90; alpha −8.6% a year (t = −0.36); last 12 months −27.7% against +18.5%.

Reported value by quarter

Bill & Melinda Gates Foundation: 13F reported value Total value of all positions in each quarter's 13F, as filed (values before 2023 were filed in thousands of dollars and are converted).
$0 $50B $100B $150B Reported value, 2020-12-31: $437.8M Reported value, 2021-03-31: $611.1M Reported value, 2021-06-30: $650.8M Reported value, 2021-09-30: $341.6M Reported value, 2021-12-31: $329.6M Reported value, 2022-03-31: $186M Reported value, 2022-06-30: $130.1M Reported value, 2022-09-30: $126.5M Reported value, 2022-12-31: $129.8B Reported value, 2023-03-31: $113.2M Reported value, 2023-06-30: $125.6M Reported value, 2023-09-30: $83.9M Reported value, 2023-12-31: $89.9M Reported value, 2024-03-31: $84.1M Reported value, 2024-06-30: $40.2M Reported value, 2024-09-30: $43.5M 2020-12-31 2021-09-30 2022-06-30 2023-03-31 2023-12-31 2024-09-30 $43.5M
View chart data
Period Reported value
2020-12-31 $437.8M
2021-03-31 $611.1M
2021-06-30 $650.8M
2021-09-30 $341.6M
2021-12-31 $329.6M
2022-03-31 $186M
2022-06-30 $130.1M
2022-09-30 $126.5M
2022-12-31 $129.8B
2023-03-31 $113.2M
2023-06-30 $125.6M
2023-09-30 $83.9M
2023-12-31 $89.9M
2024-03-31 $84.1M
2024-06-30 $40.2M
2024-09-30 $43.5M

Holdings and moves

CompanyShare of portfolioValueSharesChange in shares
BNTXBiontech SE40.59%$17.7m148.7K0.0%
VIRVir Biotechnology, Inc.26.84%$11.7m1.56M0.0%
BFLYButterfly Network, Inc.4.11%$1.8m1.01M0.0%

None this quarter.

Change in shares on the previous quarter's 13F, valued at this quarter's reported price.

None this quarter.

Change in shares on the previous quarter's 13F, valued at this quarter's reported price.

No positions in covered companies were sold out this quarter.

  • Health Care100.0%

Share of the value held in companies we cover, by sector.

PeriodCopy, a yearS&P 500SharpeS&P 500Biggest dropBeta
Whole backtestFebruary 19, 2021 to February 28, 2025−8.7%+12.6%0.000.62−70.4%0.90
Last three yearsMarch 4, 2022 to February 28, 2025−8.3%+12.9%−0.140.54−59.2%0.82
Last yearMarch 1, 2024 to February 28, 2025−25.7%+17.4%−0.590.92−35.7%0.65

From SEC Form 13F data sets. A 13F lists long positions in US-listed shares at the quarter's end, filed up to 45 days later; it does not show shorts, cash, bonds, non-US holdings or trades within the quarter. Positions in companies outside our coverage are not listed here. Research, not investment advice.